Boston Scientific: AI analysis
$44.34+0.32% today
Boston Scientific grows fast, but the share price already assumes plenty
Boston Scientific is a medical device maker with strong recent growth in heart, rhythm, and digestive care devices. To own it at today’s price, you need to believe it can keep compounding free cash flow at a healthy clip even after a run of years that already lifted sales and margins sharply. The business is good, but the current valuation leaves less room for disappointment than the recent share price slide suggests.
The verdict
Earns far more than most companies on the money it uses.
The price asks for about the growth it has delivered.
Some things could go wrong; none look urgent.
Some protection from competitors.
Written by AI on Nov 3, 2026 from company filings and prices to Nov 2, 2026.
Read the full analysis
Create a free account to read 3 AI analyses a month: the business, its moat, growth, profits, balance sheet, what the price expects, both cases and what to watch. Pro unlocks every analysis.